Takeda Pharmaceutical Company Limited
TKPHF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $7,427 | $6,621 | $6,743 | $5,602 |
| - Cash | $385 | $458 | $534 | $850 |
| + Debt | $4,515 | $5,463 | $4,382 | $4,345 |
| Enterprise Value | $11,557 | $11,627 | $10,592 | $9,097 |
| Revenue | $4,582 | $4,264 | $4,027 | $3,569 |
| % Growth | 7.5% | 5.9% | 12.8% | – |
| Gross Profit | $3,001 | $2,832 | $2,783 | $2,462 |
| % Margin | 65.5% | 66.4% | 69.1% | 69% |
| EBITDA | $1,074 | $900 | $1,156 | $1,008 |
| % Margin | 23.4% | 21.1% | 28.7% | 28.2% |
| Net Income | $108 | $144 | $317 | $230 |
| % Margin | 2.4% | 3.4% | 7.9% | 6.4% |
| EPS Diluted | 67.23 | 91.16 | 201.94 | 145.87 |
| % Growth | -26.3% | -54.9% | 38.4% | – |
| Operating Cash Flow | $1,057 | $716 | $977 | $1,123 |
| Capital Expenditures | -$380 | -$481 | -$634 | -$186 |
| Free Cash Flow | $678 | $236 | $343 | $937 |